Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data

Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark

(2011) J. L. F. Bosco et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Intensive glucose control and risk of cancer in patients with type 2 diabetes

(2011) G. Stefansdottir et al.   DIABETOLOGIA

Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

(2010) M. Monami et al.   DIABETES CARE

Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer

(2010) M. Bodmer et al.   DIABETES CARE

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

(2010) E. Mannucci et al.   DIABETES CARE

Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials

(2010) J. A. Johnson et al.   DIABETOLOGIA

Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies

(2010) C. J. Wotton et al.   DIABETOLOGIA

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

(2010) Dorothee M. Baur et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

(2009) Emily Herrett et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes

(2009) G. Libby et al.   DIABETES CARE

Does diabetes therapy influence the risk of cancer?

(2009) U. Smith et al.   DIABETOLOGIA

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

(2009) J. M. Jonasson et al.   DIABETOLOGIA

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

(2009) H. M. Colhoun et al.   DIABETOLOGIA

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

(2009) L. G. Hemkens et al.   DIABETOLOGIA

Diabetes and cancer

(2009) Paolo Vigneri et al.   ENDOCRINE-RELATED CANCER

Insulin glargine and malignancy: an unwarranted alarm

(2009) Stuart J Pocock et al.   LANCET

Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study

(2008) T. J. Murtola et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Insulin Therapy and Colorectal Adenoma Risk Among Patients with Type 2 Diabetes Mellitus: A Case-Control Study in Korea

(2008) Yong Woo Chung et al.   DISEASES OF THE COLON & RECTUM

Treatment with Insulin Secretagogues and Cancer-Related Mortality in Type 2 Diabetic Patients A Retrospective Cohort Study

(2008) M. Monami et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus

(2008) James D. Lewis et al.   GASTROENTEROLOGY